{"id":"https://openalex.org/W4401034735","doi":"https://doi.org/10.5639/gabij.2023.1201.006","title":"Non-medical switching of biologicals/biosimilars: Canada, Europe and the US \u2013 a webinar report","display_name":"Non-medical switching of biologicals/biosimilars: Canada, Europe and the US \u2013 a webinar report","publication_year":2023,"publication_date":"2023-04-15","ids":{"openalex":"https://openalex.org/W4401034735","doi":"https://doi.org/10.5639/gabij.2023.1201.006"},"language":"en","primary_location":{"id":"doi:10.5639/gabij.2023.1201.006","doi":"https://doi.org/10.5639/gabij.2023.1201.006","is_oa":false,"landing_page_url":"http://dx.doi.org/10.5639/gabij.2023.1201.006","pdf_url":null,"source":{"id":"https://openalex.org/S2764911163","display_name":"Generics and Biosimilars Initiative Journal","issn_l":"2033-6403","issn":["2033-6403","2033-6772"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-70","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Generics and Biosimilars Initiative Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046602656","display_name":"Michael S Reilly","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael S Reilly","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012609726","display_name":"Gail Attara","orcid":"https://orcid.org/0000-0001-6052-3442","observed_orcids":["https://orcid.org/0000-0001-6052-3442"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gail Attara","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104800908","display_name":"Ralph D McKibbin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ralph D McKibbin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5019702361","display_name":"Philip J. Schneider","orcid":"https://orcid.org/0000-0001-8740-809X","observed_orcids":["https://orcid.org/0000-0001-8740-809X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philip J Schneider","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"12","issue":"1","first_page":"23","last_page":"36"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9351000189781189,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9351000189781189,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.06430000066757202,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":0.9810000061988831},{"id":"https://openalex.org/keywords/biologicals","display_name":"biologicals","score":0.7580000162124634},{"id":"https://openalex.org/keywords/physician-patient-relationship","display_name":"physician-patient relationship","score":0.9330000281333923},{"id":"https://openalex.org/keywords/drug-reimbursement","display_name":"drug reimbursement","score":0.46799999475479126},{"id":"https://openalex.org/keywords/regulatory-policy","display_name":"regulatory policy","score":0.5370000004768372},{"id":"https://openalex.org/keywords/canada","display_name":"Canada","score":0.8429999947547913},{"id":"https://openalex.org/keywords/europe","display_name":"Europe","score":0.8690000176429749}],"concepts":[{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.979912519454956},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.4873979687690735},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2804887592792511},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1056469976902008}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.5639/gabij.2023.1201.006","doi":"https://doi.org/10.5639/gabij.2023.1201.006","is_oa":false,"landing_page_url":"http://dx.doi.org/10.5639/gabij.2023.1201.006","pdf_url":null,"source":{"id":"https://openalex.org/S2764911163","display_name":"Generics and Biosimilars Initiative Journal","issn_l":"2033-6403","issn":["2033-6403","2033-6772"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-70","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Generics and Biosimilars Initiative Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6240000128746033}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3216742648","https://openalex.org/W2765406213","https://openalex.org/W3085906625","https://openalex.org/W2913956994","https://openalex.org/W4400830732","https://openalex.org/W3121896434","https://openalex.org/W2907833802","https://openalex.org/W6939526711","https://openalex.org/W3002426265","https://openalex.org/W4394565963"],"abstract_inverted_index":{"Introduction:":[0],"Biosimilars":[1,74],"are":[2,24],"now":[3],"key":[4,111,202],"players":[5],"in":[6,33,68,128,163,178,203],"the":[7,48,52,61,71,93,99,106,126,132,137,142,149,167,174,188,198],"global":[8],"drugs":[9],"market":[10],"offering":[11],"potentially":[12],"more":[13],"affordable":[14],"treatment":[15],"options":[16],"with":[17,70,92],"similar":[18],"safety":[19],"and":[20,45,73,131,144,166,180,209,218,220],"efficacy.":[21],"However,":[22],"there":[23],"concerns":[25,112],"about":[26,113,187,205],"non-medical":[27,42,114,160],"switching":[28,43,115,161],"practices":[29,44,116,127,162],"of":[30,50,83,117,136,159],"originator":[31,118],"biologicals/biosimilars":[32],"different":[34],"regions.":[35],"A":[36],"webinar":[37,57,155],"was":[38,58,122,170,184,194],"held":[39,59],"to":[40,46,101],"discuss":[41],"explore":[47],"importance":[49],"safeguarding":[51,197],"physician\u2013patient":[53,199],"relationship.":[54],"Methods:":[55],"The":[56,95,154],"by":[60,89],"Alliance":[62],"for":[63],"Safe":[64],"Biologic":[65],"Medicines":[66],"(ASBM)":[67],"collaboration":[69],"Generics":[72],"Initiative":[75],"(GaBI)":[76],"on":[77,125,173],"20":[78],"July":[79],"2022.":[80],"It":[81],"consisted":[82],"various":[84],"expert":[85],"speaker":[86],"presentations":[87,138],"followed":[88],"a":[90],"Q&A":[91,143],"panel.":[94],"audience":[96],"also":[97,185],"had":[98],"opportunity":[100],"ask":[102],"questions":[103],"online":[104,151],"throughout":[105],"webinar.":[107],"Results:":[108],"Presentations":[109],"discussed":[110,140],"biological/biosimilar":[119],"medicines.":[120],"There":[121,169,183],"particular":[123],"emphasis":[124,172],"Canada,":[129,164],"Europe":[130,165],"US.":[133,168],"Further":[134],"details":[135],"were":[139,146],"during":[141],"clarifications":[145],"made":[147],"via":[148],"concurrent":[150],"Q&A.":[152],"Conclusions:":[153],"enabled":[156],"in-depth":[157],"discussion":[158,186],"specific":[171],"forced-switching":[175],"policies":[176],"adopted":[177],"Canada":[179],"their":[181],"shortcomings.":[182],"US\u2019s":[189],"interchangeability":[190],"designation.":[191],"Overall,":[192],"it":[193],"highlighted":[195],"that":[196],"relationship":[200],"is":[201],"decisions":[204],"biologicals":[206],"prescribing,":[207],"dispensing":[208],"reimbursement.":[210],"This":[211],"can":[212],"be":[213],"achieved":[214],"through":[215],"robust":[216],"policy":[217],"regulation":[219],"upholding":[221],"transparent":[222],"practices.":[223]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-07-27T00:00:00"}